ARID1A GENE MUTATION
Clinical trials for ARID1A GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new ARID1A GENE MUTATION trials appear
Sign up with your email to follow new studies for ARID1A GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill targets tough cancers in early human trial
Disease control Recruiting nowThis early-stage study is testing a new oral drug called JAB-2485 in adults with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose and see if the drug shows early signs of helping shrink tumors in cancers like certai…
Matched conditions: ARID1A GENE MUTATION
Phase: PHASE1, PHASE2 • Sponsor: Jacobio Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New Two-Drug combo tested for Tough-to-Treat uterine cancer
Disease control Recruiting nowThis study is testing whether combining two drugs, avelumab and M1774, can help control a specific type of recurrent endometrial (uterine) cancer that has a mutation in the ARID1A gene. It is for patients whose cancer has come back after prior treatment, including immunotherapy. …
Matched conditions: ARID1A GENE MUTATION
Phase: PHASE2 • Sponsor: Panagiotis Konstantinopoulos, MD, PhD • Aim: Disease control
Last updated Mar 09, 2026 14:25 UTC